
Trauma
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
This report has been verified
by one or more authors of the
original publication.
Arthroscopy. 2014 Aug;30(8):987-96
Data from 14 Level I or Level II randomized controlled trials (N=4726) was gathered in this meta-analysis. The aim of this study was to assess the efficacy of low-molecular-weight heparin venous thromboprophylaxis versus placebo/no treatment in non-major orthopaedic patients with transient reduced mobility. Findings indicated significant risk reduction of thromboembolic events with prophylactic low-molecular-weight heparin compared to the absence of prophylaxis.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.